Jan 22, 2015, 12:00
by
Michael Croft
By Clinical Informatics News Staff
January 22, 2015 | GenoSpace
announced this morning that Michelle Munson, CEO of Aspera, an IBM Company, has
joined its board as an independent director.
“We are pleased to welcome
Michelle to the leadership team at GenoSpace,” said John Quackenbush, Chairman
of the Board of GenoSpace in a statement. “We have had a strong relationship
with Michelle’s team at Aspera beginning with some of our earliest customer
deployments, and we welcome her depth of experience and clear enthusiasm for
applying advanced technical solutions to solving complex problems.”
Munson is the co-inventor of
Aspera’s fasp
transport technology. The patented, highly efficient bulk data transport
technology is used for big data transfer by Netflix, Apple, the Broad
Institute, and a wide range of other companies and markets. The fasp protocol
(fast, adaptive, secure protocol) enables much faster file transfers than any
other software or hardware wide area network (WAN) acceleration solution—all on
commodity hardware.
A year ago, Aspera’s
acquisition by IBM closed. Since then, Munson and Aspera have pushed on
toward the “science DMZ”, which Munson describes as, “a combination of
technologies that allow for unmitigated fast, efficient, and secure flow of the
large data that powers life sciences research in and out of private network
domains.”
That’s the challenge before
GenoSpace as well.
GenoSpace
applies its advanced analytical and information
integration capabilities to clinical data (it has partnerships with PathGroup
and the Multiple Myeloma Research Foundation, among others). At the Bio-IT
World Expo last year, Quackenbush said that GenoSpace plans to make
accessible data that researchers can play with in any way they want, and not to limit the types of questions that can be
asked.
Doing that means being able to
move data quickly and securely.
“GenoSpace is a highly talented
and promising team that is focused on fundamentally advancing medicine through
innovation at the intersection of genomic science and computing, an area in
which I have had significant exposure through Aspera, and which means a great deal
to me as a computer scientist,” Munson commented in the statement. “I am
honored to help contribute my experience in creating and growing a technology
start-up to this exceptional group.”